Yuanli(300174.SZ) signed an agreement with Xinfu Pharmaceutical on March 13, 2012. According to the agreement, Yuanli will acquire 100% stakes of Manzhouli Xinfu Activated Carbon Co., Ltd. (hereina...
Welcome to our website. This service is open to member only.
Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com